Comments of the Healthcare Supply Chain Association (HSCA) on USTR Request for Comments on the Proposed Modification of Action Pursuant to Section 301
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Trade Representative (USTR) on the proposed modification of action regarding Chinese exports under Section 301.
Click here for the full comments.
Related Posts
Comments of the Healthcare Supply Chain Association to FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
January 11, 2019
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Announces 2019 Board of Directors and Names GNYHA Ventures President Lee Perlman Board Chair
January 24, 2019
Washington, DC (January, 2019) – The Healthcare Supply Chain Association (HSCA)...
HSCA Names Leading National Healthcare Expert Khatereh Calleja as President & CEO
April 2, 2019
Washington, DC (April 2, 2019) – The Healthcare Supply Chain Association (HSCA)...
HSCA E&C Letter on Improving Competition in the Generic Marketplace
April 1, 2019
Dear Chairman Pallone and Ranking Member Walden, I am writing to you on behalf...